Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 5 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).

Medication burden, poor health literacy tied to inadequate bowel preparation

06 Oct 2019

Poor health literacy, functional status and number of daily medications are significantly associated with inadequate bowel preparation, which is a problem that accounts for the reduced yield of screening and increased healthcare cost, according to a study in a tertiary care setting.

A cross-sectional survey was performed in patients undergoing outpatient colonoscopy within the Johns Hopkins Health System to identify factors impacting the quality of bowel preparation.

Inadequate bowel preparation was defined as a Boston Bowel Preparation Score (BBPS) of <5. The strength of the association for selected factors with a BBPS <5 was assessed using Fisher’s exact, χ2 tests, and univariate and multivariate binary logistic regression.

A total of 467 patients (76.3 percent response rate) completed the survey between August 2017 and October 2017. The median BBPS was 7. Of the participants, 81.4 percent had an adequate bowel preparation (BBPS ≥5).

Factors associated with bowel preparation adequacy were as follows: level of education, health literacy, functional status, income and medication burden.

After adjusting for other factors, inadequate bowel preparation was significantly associated with poor confidence in filling forms (odds ratio [OR], 24.1; p<0.001), multiple daily prescription medications (OR, 12.49; p=0.02) and poor functional status (OR, 2.82; p=0.03).

“Inadequate bowel preparation is encountered in 17–32 percent of colonoscopies performed in the US,” the authors said. “Suboptimal colonic visualization reduces the yield of screening colonoscopies and increases healthcare costs because of longer procedure times and aborted procedures.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 5 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).